Meridian Bioscience (VIVO) Misses Q4 EPS by 1c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/28/2026

1. ENPH
2. HOOD
3. BA
4. STX
5. NXPI
6. KIDS
7. V
8. CSGP
9. UPS
10. MANH

Go back to Meridian Bioscience (VIVO) Misses Q4 EPS by 1c

Meridian Bioscience Reports Fourth Quarter and Full-Year Operating Results, Declares Regular Cash Dividend, and Reaffirms Fiscal 2016 Guidance

November 5, 2015 7:30 AM EST

CINCINNATI--(BUSINESS WIRE)-- Meridian Bioscience, Inc. (NASDAQ: VIVO):

GENERAL HIGHLIGHTS

Meridian Bioscience, Inc., Cincinnati, Ohio (NASDAQ: VIVO) today:

reported fourth quarter and record full-year fiscal 2015 net revenues of $47.1 million and $194.8 million, respectively, increases of 1% and 3%, respectively, from the same periods of the prior fiscal year; reported fourth quarter and full-year fiscal 2015 operating income of $13.3 million and $56.1 million, respectively, increases of 11% and 7%, respectively, from the same periods of the prior fiscal year; reported... More